These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2878578)

  • 1. Characterization of dopamine D-1 and D-2 receptors.
    Hyttel J; Arnt J
    Adv Exp Med Biol; 1986; 204():15-28. PubMed ID: 2878578
    [No Abstract]   [Full Text] [Related]  

  • 2. The dopamine D1 receptor: biochemical and behavioral aspects.
    Andersen PH; Nielsen EB
    Adv Exp Med Biol; 1986; 204():73-91. PubMed ID: 2878580
    [No Abstract]   [Full Text] [Related]  

  • 3. Functional interactive effects of D1 and D2 dopamine receptor blockade.
    Salama AI; Saller CF
    Adv Exp Med Biol; 1986; 204():137-50. PubMed ID: 2947425
    [No Abstract]   [Full Text] [Related]  

  • 4. Selective blockade of dopamine D-1 receptors by SCH 23390 discloses striatal dopamine D-2 receptors mediating the inhibition of adenylate cyclase in rats.
    Onali P; Olianas MC; Gessa GL
    Eur J Pharmacol; 1984 Mar; 99(1):127-8. PubMed ID: 6233165
    [No Abstract]   [Full Text] [Related]  

  • 5. Loss of rat striatal dopamine receptors with ageing is selective for D-2 but not D-1 sites: association with increased non-specific binding of the D-1 ligand [3H]piflutixol.
    O'Boyle KM; Waddington JL
    Eur J Pharmacol; 1984 Oct; 105(1-2):171-4. PubMed ID: 6149143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical and behavioral studies of D1 dopamine receptors utilizing SCH 23390.
    Hess EJ; Creese I
    Adv Exp Med Biol; 1986; 204():29-52. PubMed ID: 2878579
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular mechanisms involved in the desensitization of dopamine receptors in slices of corpus striatum.
    Hanbauer I; Sanna E
    Prog Brain Res; 1986; 69():161-8. PubMed ID: 2965820
    [No Abstract]   [Full Text] [Related]  

  • 8. Biochemical and functional characterization of central dopamine receptors.
    Goldstein M; Lew JY; Meller E
    Adv Exp Med Biol; 1988; 235():43-53. PubMed ID: 2976253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of chronic ethanol treatment on dopamine receptor subtypes in rat striatum.
    Lucchi L; Moresco RM; Govoni S; Trabucchi M
    Brain Res; 1988 May; 449(1-2):347-51. PubMed ID: 2969275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct target size of dopamine D-1 and D-2 receptors in rat striatum.
    Nielsen M; Klimek V; Hyttel J
    Life Sci; 1984 Jul; 35(3):325-32. PubMed ID: 6235424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substituted benzamides as cerebral dopamine antagonists in rodents.
    Elliott PN; Jenner P; Huizing G; Marsden CD; Miller R
    Neuropharmacology; 1977 May; 16(5):333-42. PubMed ID: 559256
    [No Abstract]   [Full Text] [Related]  

  • 12. Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain.
    Seeman P; Niznik HB; Guan HC; Booth G; Ulpian C
    Proc Natl Acad Sci U S A; 1989 Dec; 86(24):10156-60. PubMed ID: 2574862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of solubilized dopamine receptors from dog striatum.
    Gorissen H; Aerts G; Laduron P
    FEBS Lett; 1979 Apr; 100(2):281-5. PubMed ID: 37113
    [No Abstract]   [Full Text] [Related]  

  • 14. Cocaine administration: D1 dopamine receptor function and dopamine clearance/diffusion in rat striatum and nucleus accumbens.
    Zahniser NR; Mayfield RD; Cass WA; Gerhardt GA
    Ann N Y Acad Sci; 1992 Jun; 654():537-9. PubMed ID: 1385936
    [No Abstract]   [Full Text] [Related]  

  • 15. Dopamine-receptor binding and adenylate-cyclase activity in mouse striatal tissue in the supersensitivity phase after neuroleptic treatment.
    Hyttel J
    Psychopharmacology (Berl); 1978 Dec; 59(3):211-6. PubMed ID: 32570
    [No Abstract]   [Full Text] [Related]  

  • 16. Apparent dopamine D1 and D2 receptors in the weaver mutant mouse: receptor binding and coupling to adenylyl cyclase.
    Dewar KM; Paquet M; Sequeira A
    J Neural Transm (Vienna); 1999; 106(5-6):487-97. PubMed ID: 10443552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute and chronic amphetamine treatments modulate striatal dopamine receptor binding sites.
    Howlett DR; Nahorski SR
    Brain Res; 1979 Jan; 161(1):173-8. PubMed ID: 758968
    [No Abstract]   [Full Text] [Related]  

  • 18. Ontogenesis of dopamine receptor binding in the corpus striatum of the rat.
    Pardo JV; Creese I; Burt DR; Snyder SH
    Brain Res; 1977 Apr; 125(2):376-82. PubMed ID: 851885
    [No Abstract]   [Full Text] [Related]  

  • 19. Dopamine receptors localised on cerebral cortical afferents to rat corpus striatum.
    Schwarcz R; Creese I; Coyle JT; Snyder SH
    Nature; 1978 Feb; 271(5647):766-8. PubMed ID: 625348
    [No Abstract]   [Full Text] [Related]  

  • 20. Increased sensitivity in the interaction of the dopaminergic/adenosinergic system at the level of the adenylate cyclase activity in the striatum of the "weaver" mouse.
    K B; V T; N P; M M; N M; F A
    Neurochem Int; 2016 Oct; 99():233-238. PubMed ID: 27498335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.